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AbsTrACT
Universal health coverage (UHC) has been identified as a 
priority for the global health agenda. In 2009, the Chinese 
government launched a new round of healthcare reform 
towards UHC, aiming to provide universal coverage of 
basic healthcare by the end of 2020. We conducted a 
secondary data analysis and combined it with a literature 
review, analysing the overview of UHC in China with regard 
to financial protection, coverage of health services and 
the reported coverage of the WHO and the World Bank 
UHC indicators. The results include the following: out- of- 
pocket expenditures as a percentage of current health 
expenditures in China have dropped dramatically from 
60.13% in 2000 to 35.91% in 2016; the health insurance 
coverage of the total population jumped from 22.1% 
in 2003 to 95.1% in 2013; the average life expectancy 
increased from 72.0 to 76.4, maternal mortality dropped 
from 59 to 29 per 100 000 live births, the under-5 
mortality rate dropped from 36.8 to 9.3 per 1000 live 
births, and neonatal mortality dropped from 21.4 to 4.7 
per 1000 live births between 2000 and 2017; and so on. 
Our findings show that while China appears to be well 
on the path to UHC, there are identifiable gaps in service 
quality and a requirement for ongoing strengthening of 
financial protections. Some of the key challenges remain 
to be faced, such as the fragmented and inequitable 
health delivery system, and the increasing demand for 
high- quality and value- based service delivery. Given that 
China has committed to achieving UHC and ‘Healthy China 
2030’, the evidence from this study can be suggestive 
of furthering on in the UHC journey and taking the policy 
steps necessary to secure change.
InTroduCTIon
Universal health coverage (UHC) has been 
identified as a priority for the global health 
agenda. UHC means that all people can 
access the health services they need, without 
suffering financial hardship,1 and became 
a critical part of the Sustainable Develop-
ment Goals (SDGs) in 2015.2 In September 
2019, all United Nations Member States have 
committed strongly to achieve UHC by 2030, 
with the global effort to build a healthier 
world for all.3 Measuring progress towards 
UHC is complex due to the different political 
contexts among countries. In 2015, the WHO 
and the World Bank (WB) jointly launched a 
monitoring framework for UHC and reported 
the first global assessment of the progress 
towards UHC. Subsequently, a second report 
was published in 2017, more specifically 
monitoring SDG 3 target 3.8. The second 
framework built on two SDG UHC indicators: 
coverage of essential health services (target 
3.8.1) and financial protection (target 3.8.2).1 
Such an evaluation framework will provide 
guidance for assessing UHC in a country and 
tracking progress over time, and be mean-
ingful in making cross- country comparisons.
Since the Chinese government launched 
a new round of health system reform in 
2009, China has made tremendous efforts 
to achieve the long- term objective of 
UHC—providing affordable and equitable 
basic healthcare for all by 2020.4 A series of 
comprehensive healthcare reforms have been 
adopted step by step, including the expansion 
of healthcare insurance, making basic public 
summary box
 ► Universal health coverage (UHC) has been identified 
as a priority for the global health agenda in many 
countries, including China.
 ► Out- of- pocket expenditures as a percentage of 
current health expenditures in China have dropped 
dramatically.
 ► The health insurance reform is achieved in the 
breadth of coverage in the population, the compre-
hensiveness of the benefits packages and increased 
reimbursement rates.
 ► The coverage of healthcare services greatly pro-
gressed in terms of accessibility, equity and quality, 
but it remains to be improved in some aspects, such 
as quality in non- communicable diseases.
 ► Taking the next steps is suggested when the Chinese 
government encounters some key challenges to 
achieve UHC.
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Figure 1 Trends in the core indicators of health systems financing in China and OECD members between 2000 and 2016. 
The core indicators are according to the ‘Health Systems Financing- Toolkit on monitoring health systems strengthening, 
WHO, 2008’. Source: The World Bank data (https://data.worldbank.org; last updated: 8 October 2019). CHE, current health 
expenditure; GDP, gross domestic product; GGE, general government expenditure; GGHE- D, domestic general government 
health expenditure; OECD, Organisation for Economic Co- operation and Development; OOPE, out- of- pocket expenditure.
health services available and equal for all, establishing 
a national essential medicines system, improving the 
primary care delivery system to provide basic healthcare, 
and the reform of public hospitals.5 This year marks the 
10th anniversary of the healthcare reform. It is especially 
timely and significant to assess and track progress towards 
UHC in China. However, very few evaluations have been 
conducted on this issue.
This study aims to analyse China’s progress towards 
UHC in the past 10 years of healthcare reform, based 
on two dimensions: financial protection and coverage 
of health services. We also tracked UHC indicators by 
the latest WHO and WB framework in our analysis, and 
conclude with a discussion of the remaining challenges 
towards UHC. Due to the constraints of the available data, 
we conducted a secondary data analysis from multiple 
sources: public databases (eg, WHO and WB), related 
reports, the China Statistical Yearbook, the National 
Health Services Survey (NHSS) in China and so on. To 
present a comprehensive and detailed picture of UHC in 
China, we combined our analysis with a literature review 
and summarised findings from the peer- reviewed orig-
inal research. The search method, search strategy and 
included papers are listed in online supplementary file 
2. Findings from this analysis will provide evidence for 
policy- makers on the path to achieving UHC and recom-
mendations for the next step moving forward in China.
FInAnCIAl proTeCTIon
Financial protection is critical to reaching UHC, as all 
citizens should have access to health services without 
suffering financial hardship. Figure 1 shows the trends in 
the core indicators of health systems financing in China 
and the members of the Organisation for Economic 
Co- operation and Development (OECD) between 2000 
and 2016. Compared with OECD members, China spent 
less of its gross domestic product on health, but the total 
health expenditures still grew. Although Chinese govern-
ment spending on health increased to 9.05% of its total 
expenditure in 2016, it is far less than the share of OECD 
countries. The out- of- pocket spending is a key indi-
cator with regard to financial protection. Out- of- pocket 
expenditures (OOPE) as a percentage of current health 
expenditures in China have dropped dramatically from 
60.13% in 2000 to 35.91% in 2016, but remain signifi-
cantly higher in China than in OECD member countries. 
The amount of OOPE per capita continued to increase.6 
Online supplementary figure S1 shows the total health 
expenditure composition in China from 2000 to 2018. 
As for the indicator of catastrophic health expenditure, 
recent national studies showed that China made progress 
in reducing the rate of catastrophic health expenditure, 
especially for low- income groups.7 8 However, the finan-
cial burden for medical services of patients remains 
high.9 10
The achievements of health insurance reform in China 
are impressive for both the scale of coverage expansion 
and the speed of expansion.11 The NHSS showed a rapid 
increase in coverage over the past decade for both the 
urban and rural populations (figure 2). The health insur-
ance coverage of the total population jumped from 22.1% 
in 2003 to 95.1% in 2013. The gap of insurance coverage 
was greatly narrowed between the urban and rural areas, 
reducing inequality. According to the evaluation frame-
work on health insurance programmes coverage by Lago-
marsino and colleagues,12 we examined the coverage 
of basic social health insurance programmes in China 
across three dimensions: who is covered, what is covered 
Tao W, et al. BMJ Global Health 2020;5:e002087. doi:10.1136/bmjgh-2019-002087 3
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Figure 2 Changes in the basic health insurance coverage of the survey population in different years. UEBMI, NRCMS and 
URBMI were established in 1998, 2003 and 2007, respectively. Adapted from ‘the fifth national health service survey analysis 
report in 2013’.39 NRCMS, New Rural Cooperative Medical Scheme; UEBMI, Urban Employee Basic Medical Insurance; 
URBMI, Urban Resident Basic Medical Insurance.
Table 1 Three dimensions of coverage on basic social health insurance programmes in China
Who is covered? What is covered? How much is covered?
Eligible 
population83
Population 
covered 
(millions)13
Service package 
covered84
Drugs covered 
(n)85–87
Per capita 
premium (¥)13 
88
Government 
subsidy per 
capita (¥)13 89
UEBMI Urban, employed. 219.4 (2009)*
316.8 (2018)
Inpatient services, 
catastrophic 
outpatient services, 
some prevention care 
services.
2151 (2009)
2643 (2019)
1559.2 (2009)* 
4273.2 (2018)
0
URBMI Urban, non- 
employed.
182.1 (2009)* Mainly cover 
inpatient services and 
catastrophic outpatient 
services.
2151 (2009) 130 (2009) 80 (2009)
NRCMS Rural, employed 
and non- 
employed.
833.1 (2009)*
130.4 (2018)†
Inpatient services, 
catastrophic 
outpatient services, 
some prevention care 
services.
County 800–
1200, town 300–
500 (2008)
113.4 (2009) 80 (2009)
URRMI Unemployed 
urban residents 
and rural 
residents.
897.4 (2018) Inpatient services (up 
to 75%) and outpatient 
services.
2643 (2019) 693 (2018) 497 (2018)
¥7=US$1.
*Data are from China Statistical Yearbook 2010.
†To integrate the fragmented health insurance, the Chinese government merged URBMI and NRCMS into URRMI in 2016. There are still 
seven provinces implementing the NRCMS in 2018, including Liaoning, Jilin, Anhui, Hainan, Guizhou, Shanxi and Tibet.
NRCMS, New Rural Cooperative Medical Scheme; UEBMI, Urban Employee Basic Medical Insurance; URBMI, Urban Resident Basic 
Medical Insurance; URRMI, Urban and Rural Resident Medical Insurance.
and how much is covered (table 1). Significant achieve-
ments were realised on the breadth of coverage in the 
population, the comprehensiveness of the benefits pack-
ages and increased reimbursement rates. In 2018, 1.34 
billion people participated in the basic health insurance 
nationwide, with a steady coverage of more than 95%.13 
In each insurance scheme, the benefit of health service 
package was improved, and the number of pharmaceu-
ticals on the drug list was expanded to 2643 in 2019. 
Currently, there is no variation in the number of drugs 
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Figure 3 Changes in NBPHS programme, 2009–2018. Sources: Data on government investment in basic public health 
service are from the National General Public Budget Expenditure of National Government Final Accounts released by the 
Financial Ministry of the People’s Republic of China every year from 2009 to 2018. Data on per capita subsidy are from the 
news and Statistical Bulletin released by the National Health Commission of the People’s Republic of China. Data on basic 
public health services are from National Basic Public Service Specifications in 2009, 2011 and 2017, and Qin’s and Wang et 
al’s research.90 91 *Public health emergency reporting and assistance for health inspection, and the target services group for 
children’s health management extended from 0–3 years to 0–6 years. CNY, Chinese yuan; NBPHS, national Basic Public Health 
Service; TB, tuberculosis; TCM, traditional Chinese medicine.
covered by the different insurance schemes. Along with 
an increase in the per capita premiums for the Urban 
Resident Basic Medical Insurance and the New Rural 
Cooperative Medical Scheme, government subsidies 
per capita have increased more than fivefold in 2018 
compared with 2009. China’s health insurance system 
has been proven to be effective in boosting the utilisation 
of healthcare services and alleviated the financial burden 
of patients.14 15 The integration of fragmented health 
insurance schemes could promote access to and improve 
equity in healthcare utilisation for rural residents.16 17 
However, some of the populations, such as children,18 
lower income groups19 and rural- to- urban migrants,20 21 
have a lower rate of insurance coverage.
CoverAge oF HeAlTH servICes
The national Basic Public Health Service (BPHS) 
programme was launched in 2009 to provide free basic 
public health services for all urban and rural residents 
equally. Figure 3 shows the Chinese government’s efforts 
in this area. To regulate the guideline for basic services, 
three editions of BPHS specifications were issued in 2009, 
2011 and 2017, respectively. The initial service package 
consists of nine categories, including health archive 
management, health education, vaccination, commu-
nicable disease reporting, health management for chil-
dren, maternal and elderly, and health management for 
chronic diseases and severe psychosis. Increased govern-
ment public funding was invested to expand the services 
(14 categories in 2017) and availability of the basic 
public health package to almost everyone. An average 
of ¥15 was allotted per capita in 2009 and was increased 
to ¥55 in 2018. Following the previous literature, find-
ings of the studies showed the following: the coverage 
of BPHS has increased greatly, but it has not reached 
the goal of universal coverage,22 23 especially coverage 
of migrants24 25; the utilisation of the BPHS is generally 
improved, but some of the services are underutilised26 27; 
ensuring equal access to the basic public health services 
is improved,28 29 and the gaps between urban–rural areas 
and different regions have been narrowed, but inequality 
still exists24 30 31; and with respect to the effects of the 
BPHS policy, there are some improvements in maternal 
health services and reductions in maternal mortality,32 
and improved the treatment and control among patients 
with hypertension and type 2 diabetes.33 34 New evidence 
from the Global Burden of Disease Study showed that 
China has made substantial progress in reducing the 
burden of many diseases and disabilities.35
According to the China Health Statistics Yearbook, 
the utilisation of medical services increased between 
2009 and 2018: the outpatient visits increased from 
518.7 million to 797.8 million, the hospital admissions 
increased from 132.6 million to 254.5 million, and the 
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Figure 4 Comparison of the visits in hospitals and primary healthcare institutions, 2009–2018. Sources: China Statistical 
Yearbook, 2010–2018; China Health Statistics Yearbook, 2019. H, hospital; PCI, primary care institutions.
annual resident hospitalisation rate increased from 
9.95% to 18.27%. Accordingly, both the number of 
visits to hospitals and primary care institutions (PCIs) 
increased. However, the percentage of visits delivered 
by hospitals among all healthcare institutions increased 
from 35.02% to 43.06%, while the proportion accounted 
for by PCIs dropped from 61.82% to 53.04% (figure 4). 
It indicates the current disordered situation—medical 
services are increasingly concentrated in hospitals rather 
than in primary care.
Delivering healthcare services in an accessible and equi-
table manner is essential to the goal of UHC. Access to 
health services has improved since the healthcare reform 
of 2009,36 37 but regional disparity is also apparent.37 38 
Compared with 2008, the proportion of people who were 
not hospitalised due to financial difficulties decreased 
significantly, from 17.6% in 2008 to 7.4% in 2013.39 It 
indicated that the affordable access to healthcare services 
was improved, but some studies showed that the finan-
cial burden remains heavy,40 41 and the current reform 
has not resulted in access to affordable quality care.42 
With the increase in government investments, the total 
amount of healthcare resources has increased in China 
and the equity of health resource allocation improved 
gradually.43–45 However, inequity in healthcare resources 
and services still existed. The inequitable determinants 
may relate to region,46 income47 and insurance type.46–49 
Figure 5 shows the gap between urban and rural areas in 
resource allocation. Between 2005 and 2017, the number 
of medical technical personnel, licensed (assistant) 
doctors, registered nurses and beds per 1000 population 
in urban areas grew more than in rural areas. According 
to the fifth NHSS in 2013, maternal and child health 
indicators (eg, the proportion of women receiving at 
least five antenatal check- ups, the proportion of children 
qualifying physical examination) in Central China were 
the poorest of the three regions (Western, Central and 
Eastern China). To achieve ‘effective UHC’, ensuring 
good quality of healthcare services should be emphasised 
as well.50 51 According to a recent global study, China has 
significantly increased personal healthcare access and 
quality, with an increase in the Healthcare Access and 
Quality Index (HAQ) score from 56.2 in 1990 to 78 in 
2016.52 Although large HAQ score gaps remain between 
subnational regions, the expanded coverage of health 
services has led to health improvements, particularly 
for residents in rural areas. During the period between 
2000 and 2017, the average life expectancy increased 
from 72.0 to 76.4, maternal mortality dropped from 59 
in to 29 per 100 000 live births, the under-5 mortality 
rate dropped from 36.8 to 9.3 per 1000 live births, and 
neonatal mortality dropped from 21.4 to 4.7 per 1000 
live births (online supplementary file 1, table S1). The 
differences in the neonatal, infant, under-5 and maternal 
mortality rates between urban and rural have greatly 
narrowed (figure 6).
Health services, broadly understood, also include the 
provision of drugs, devices and other goods, especially 
the essential medicines.53 Assuring access to essential 
medicines is also crucial for moving towards UHC.54 As 
part of the commitment to giving every citizen access to 
basic healthcare, China implemented the National Essen-
tial Medicines Policy (NEMP), which aims to increase the 
availability and affordability and to ensure the quality and 
promote the rational use of medicines. Since the revision 
of the National Essential Medicines List (NEML) issued in 
2009, the list has been updated constantly from 307 medi-
cines (2009) to 520 medicines (2012) and 685 medicines 
6 Tao W, et al. BMJ Global Health 2020;5:e002087. doi:10.1136/bmjgh-2019-002087
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Figure 5 The gap between urban and rural medical resources, 2005–2017. Source: China Statistical Yearbook, 2006–2018. 
LD, licensed (assistant) doctors; MTP, medical technical personnel; RN, registered nurses.
Figure 6 Neonatal, infant, under-5 children and maternal mortality rate between urban and rural areas, 2000–2018. Source: 
China Health Statistics Yearbook, 2019. IMR, infant mortality rate; MMR, maternal mortality rate; NMR, neonatal mortality rate; 
U5MR, under-5 mortality rate.
(2018), for fully meeting the needs of basic healthcare.55 
Based on the literature review on the evaluation of the 
effects of the NEMP, there is no consensus conclusion. 
Differences in research conclusions may be due to the use 
of data from different regions, research period or study 
design. But overall, these findings have demonstrated 
that the NEMP interventions are effective: the availability 
of essential medicines had improved,56 57 but remains at 
a low level58 59 and had a problem of regional inequity60; 
drug prices were reduced significantly,57 61–63 and the 
affordability of essential medicines has improved57 59 60; 
and the rational use of medicine has effectively improved, 
but remained poor.56 64–67 In the subjective questionnaire 
surveys, patients were satisfied with the price and quality 
of essential medicines.68 However, village doctors were 
unsatisfied with the NEML; most of them believed that 
the NEML could not meet the needs of the villagers.69
MonITorIng And evAluATIon oF uHC IndICATors
To evaluate China’s UHC and compare it with other 
countries, we used the indicator framework defined in 
the Joint WHO/WB report entitled ‘Tracking Universal 
Health Coverage: 2017 Global Monitoring Report’.1 
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China has comparatively high coverage of essential 
health services but a low score for financial protection 
against catastrophic health expenditures. We analysed 
secondary data from international and national data sets 
to evaluate trends in indicators (refer to online supple-
mentary figure S2 for the trends from 2000 to 2017, and 
online supplementary file 1, table S2 for detailed indica-
tors and data sources).
In terms of health service coverage, all indicators 
demonstrate improvement, with the exception of family 
planning. However, the level of demand satisfied by 
modern methods in 2017 (80.5%) is considered high, 
which is more than 75%.70 The largest relative increases 
are for tuberculosis (TB) and HIV treatment, which 
are consistent with global trends. This reflects China’s 
concerted efforts in the prevention and treatment of 
infectious diseases, for example, national ‘Action Plans’ 
to stop TB and HIV.71 72 However, progress in non- 
communicable diseases has been slower; in particular, 
blood glucose control (diabetes management) is dete-
riorating. Although the number of patients covered 
by type 2 diabetes management (including screening, 
regular follow- up and health education) increased from 
18.5 million in 2011 to 31.2 million in 2017, blood glucose 
control rate has remained persistently low, indicating 
that the expanded service coverage may lack quality.73 
More efforts are needed to develop effective strategies to 
control chronic diseases.
The upward trends in hospital beds, physicians and 
health security indicate greatly improved service capacity 
and access. In terms of financial protection, the risk 
of financial hardship due to out- of- pocket healthcare 
costs increased during 2000 and 2007, as measured by 
a growing incidence of OOPE exceeding 10% or 25% 
of household total consumption or income and an 
increased incidence of impoverishment at the $3.10 per 
day poverty line. However, the poverty gap due to OOPE 
(ie, the average per capita amount by which OOPE 
pushes or further pushes households below the poverty 
line)1 decreased for both poverty lines.
CHAllenges And polICy reCoMMendATIons
China has made unprecedented achievements on the 
path to realising UHC, but still faces a series of challenges 
when the healthcare system is subjected to multiple and 
persistent pressures, such as the changes in the distribu-
tion of diseases, urbanisation and a rapidly ageing popu-
lation.
China’s healthcare system is facing a considerable 
challenge of fragmented healthcare delivery: hospital- 
centred and treatment-dominated. The current health-
care services in China still rely on hospital care, and 
PCIs do not play an important role in providing the 
basic healthcare with the first level of contact. Patients 
prefer to seek care in higher level of hospitals instead 
of primary healthcare (PHC) providers due to various 
factors, such as equipment and drug availability, 
medical staff, and perceived quality of primary care.74 75 
The overdependence on hospital care not only leads to 
heavy financial burden and barriers to accessing basic 
healthcare, but also makes it difficult to form effec-
tive and continuous management of chronic diseases. 
There is a need for urgency in transition from frag-
mented care to integrated care in China’s healthcare 
systems. The key solution is the establishment of a 
tiered healthcare delivery system based on a people- 
centred integrated care model that can coordinate the 
PHC and hospital care.76 77 Thus, the service integra-
tion between PCIs and higher- level hospitals can be 
achieved through two- way referral, cooperation and 
information sharing among providers and between 
providers and patients, and active patient involvement 
in their continuous care.78
The second challenge is the persistent inequity in 
healthcare delivery between urban and rural areas, 
and among different income regions. Despite substan-
tial improvements in access to health services and the 
dramatic reductions in poverty, inequalities still exist. 
Urban–rural disparities in financing and health services 
access are major issues in China when promoting UHC.79 
Given China’s urban–rural dualistic economic structure, 
uncoordinated development in the healthcare system 
has led to more and better healthcare resources in urban 
areas,80 especially with regard to health personnel, and 
the differences in regional economic development tend 
to be the cause of the regional inequity. China needs to 
make more progress with respect to equity in health-
care in the future healthcare reforms. Except that policy 
is tilted in favour of resource- poor regions, the devel-
opment of the Healthcare Alliance (HCA) is a priority 
issue. HCA refers to a collaborative alliance or medical 
group consisting of different types and levels of health-
care organisations in the same region or across regions. 
It is able to promote optimal healthcare resources allo-
cation and flow, and improve the capability of primary 
care. Based on the HCA, strengthening the health infor-
mation technology, such as mobile health and telemed-
icine, can help solve regional disparities and shortage 
of health personnel (especially for the low- income and 
remote areas) and promote homogenisation of health-
care services. At the same time, we need to coordinate 
the reform of medicine and health insurances to improve 
health equity.
The third challenge is to develop health services that 
can meet the emerging health needs of socioeconomic 
and demographic transitions. Given the rapidly rising 
incidence of non- communicable diseases and a rapidly 
ageing population, the health strategy should shift from 
treatment to prevention, calling for more comprehen-
sive approaches to serving population health rather than 
solely the patient’s health.81 82 Meanwhile, with increased 
economy and improved lifestyle, people are demanding 
more and better healthcare. More attention should pay to 
building high- quality and value- based service delivery.78 
The coverage of basic health services has been basically 
8 Tao W, et al. BMJ Global Health 2020;5:e002087. doi:10.1136/bmjgh-2019-002087
BMJ Global Health
achieved; therefore, improving the quality of services is 
the next step.
ConClusIon
This analysis gives an overview of UHC in China with 
regard to health financing, healthcare services and the 
reported coverage of WHO/WB indicators. It is the 
first attempt to integrate WHO/WB framework into a 
summary measure of UHC in China. Our findings show 
that while China appears to be well on the path to UHC, 
there are identifiable gaps in service quality and a require-
ment for ongoing strengthening of financial protections. 
Some of the key challenges remain to be faced, such as 
the fragmented and inequitable health delivery system, 
and the increasing demand for high- quality and value- 
based service delivery. Given that China has committed to 
achieving UHC and ‘Healthy China 2030’, the evidence 
from this study can be suggestive of furthering on in the 
UHC journey and taking the policy steps necessary to 
secure change.
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